Johnson Louis D V, Pickard Mark R, Johnson William E B
Chester Medical School, University of Chester, Chester CH1 4BJ, UK.
University Centre Shrewsbury, University of Chester, Shrewsbury SY3 8HQ, UK.
Biology (Basel). 2021 Mar 16;10(3):230. doi: 10.3390/biology10030230.
Animal models have been used in preclinical research to examine potential new treatments for spinal cord injury (SCI), including mesenchymal stem cell (MSC) transplantation. MSC transplants have been studied in early human trials. Whether the animal models represent the human studies is unclear. This systematic review and meta-analysis has examined the effects of MSC transplants in human and animal studies. Following searches of PubMed, Clinical Trials and the Cochrane Library, published papers were screened, and data were extracted and analysed. MSC transplantation was associated with significantly improved motor and sensory function in humans, and significantly increased locomotor function in animals. However, there are discrepancies between the studies of human participants and animal models, including timing of MSC transplant post-injury and source of MSCs. Additionally, difficulty in the comparison of functional outcome measures across species limits the predictive nature of the animal research. These findings have been summarised, and recommendations for further research are discussed to better enable the translation of animal models to MSC-based human clinical therapy.
动物模型已被用于临床前研究,以检验脊髓损伤(SCI)的潜在新疗法,包括间充质干细胞(MSC)移植。MSC移植已在早期人体试验中进行了研究。动物模型是否能代表人体研究尚不清楚。本系统评价和荟萃分析研究了MSC移植在人体和动物研究中的效果。在检索了PubMed、临床试验和Cochrane图书馆后,对已发表的论文进行了筛选,并提取和分析了数据。MSC移植与人类运动和感觉功能的显著改善以及动物运动功能的显著增加相关。然而,人体参与者研究和动物模型之间存在差异,包括损伤后MSC移植的时间和MSC的来源。此外,跨物种功能结局测量比较的困难限制了动物研究的预测性。这些发现已被总结,并讨论了进一步研究的建议,以更好地将动物模型转化为基于MSC的人类临床治疗。